Tempus
AI-powered precision oncology platform analyzing clinical and molecular data for personalized cancer care.
Tempus stands out for its massive real-world data library and AI-driven insights, making it a strong choice for oncologists and researchers in large institutions. However, its enterprise-only pricing and complexity limit accessibility for small practices. If you need genomic profiling, consider Foundation Medicine; for real-world evidence, Flatiron Health offers competitive options. Tempus delivers unmatched depth if you have the budget and IT support.
Verified 3d ago · liveness 73/100 · cite: rightaichoice.com/tools/tempus
- Oncologists in large health systems needing AI-driven treatment recommendations
- Pharmaceutical companies requiring real-world evidence for drug development
- Cancer researchers needing large-scale de-identified patient data analytics
- Academic medical centers with IT infrastructure for molecular profiling
- Small independent clinics without enterprise budget
- Patients seeking direct-to-consumer genetic testing
- Providers needing a simple single-gene test
We scan live Reddit threads, YouTube comments, X posts, G2 reviews and other communities — and hand you an honest verdict in under a minute.
- Honest verdict, not marketing
- Real pros & cons from real users
- Attributed quotes with receipts
3 free scans · no card needed
Skip Tempus if you're a small practice or independent clinic without enterprise budget and dedicated IT support, or if you need transparent, upfront pricing.
Enterprise-only pricing means you must engage in a sales cycle to get a quote, with no public price list to compare.
Tempus pricing is tailored for large health systems and pharma enterprises with substantial budgets; it's not competitive for small practices. Compared to Foundation Medicine and Flatiron Health, Tempus offers deeper data integration but at a higher cost, and you'll need to negotiate a custom contract.
In short
Tempus — AI-powered precision oncology platform analyzing clinical and molecular data for personalized cancer care. Best for Oncologists in large health systems needing AI-driven treatment recommendations, Pharmaceutical companies requiring real-world evidence for drug development, Cancer researchers needing large-scale de-identified patient data analytics. Contact Sales pricing.
What people actually say about Tempus — is it worth it?
We ran a structured research pass across product reviews, community discussions, and post-purchase forum threads to surface the patterns vendors won't publish themselves. Below: the recurring strengths, the hidden costs people mention most, and the cohort that consistently regrets adopting this tool.
70 mentions across 5 sources (Hacker News, YouTube, Product Hunt, GitHub, Lemmy) · researched Aug 24, 2026.
- +Real-world evidence generation with 7M+ de-identified records.
- +Multimodal data integration (genomic, clinical, imaging) for holistic view.
- +Tempus xT panel covers 648 genes for comprehensive sequencing.
- +Cloud-based Tempus LENS enables advanced analytics and research.
- +Clinical trial matching helps patients access experimental options.
- −Little direct community feedback; user experience largely unverified.
- −Pricing is opaque, with no published tiers or transparent costs.
- −Legal battles over genetic data mining raise privacy red flags.
- −Integration options undocumented, limiting ecosystem interoperability.
- −Intended for advanced users; learning curve for non-technical clinicians.
- • Implementation and onboarding fees are likely
- • Data integration and storage costs may be extra
- • Contract minimums probably required for enterprise deals
Viability Score
How well maintained and how widely used is Tempus? Built from what the vendor actually publishes (docs, changelog, tutorials, integrations, pricing), whether the site is live, and how much real users discuss it. How we calculate this
Last calculated: September 2026
How we score →Key Features
- Tempus xT DNA/RNA sequencing panel (648 genes)
- Tempus LENS cloud-based analytics tool
- Real-world evidence generation
- De-identified patient record aggregation (7M+ records)
- Genomic alteration detection
- Treatment outcome prediction
- Clinical trial matching
- Multimodal data integration (genomic, clinical, imaging)
- Physician decision support
- Tempus PRO AI-assisted notetaking for neurologists
- ECG-AI for cardiovascular patient identification
- Tempus Pixel radiology therapy response evaluation
- Pharmaceutical research data access
- AI model building tools for research
- Integration with EHR systems (documented)
About Tempus
Tempus is a health technology company that leverages artificial intelligence and a vast library of clinical and molecular data to enable personalized cancer care. By analyzing de-identified patient records and genomic sequencing data, Tempus provides actionable insights to physicians, helping them make more informed treatment decisions. The platform offers a suite of products including Tempus xT, a DNA/RNA sequencing panel that detects relevant genomic alterations, and Tempus LENS, a cloud-based analytics tool for real-world evidence generation. With over 7 million de-identified clinical records and a network of over 8,000 clinicians, Tempus empowers researchers and healthcare providers with data-driven tools. Its partnerships with pharmaceutical companies and academic institutions accelerate clinical trials and drug discovery. Unlike traditional diagnostics, Tempus' AI-driven approach integrates multimodal data for a comprehensive view of a patient's cancer, positioning it as a leader in precision oncology.
Behind the Verdict
Tempus is not a tool you adopt lightly; it's a platform you build your oncology practice or research program around. The core strength is the integration of de-identified clinical records (7M+) with genomic sequencing data, enabling a level of multimodal insight that few competitors match. For a large health system, the Tempus xT panel (648 genes) provides actionable genomic profiling that can inform targeted therapy choices, while LENS offers a cloud-based analytics environment for mining real-world evidence. This is a major asset for researchers and pharma partners aiming to accelerate drug discovery. However, the enterprise-only pricing and lack of public transparency mean you must engage in a sales cycle to understand costs, which can be prohibitive for small practices. The platform's complexity also demands dedicated IT support for integration and ongoing use, adding hidden operational costs. If you are a solo oncologist or a small clinic, the ROI is likely negative compared to simpler, more affordable options. For pharma companies, Tempus provides a rich dataset and AI model-building tools, but you need to weigh the cost against alternatives like Flatiron Health's data offerings. For health systems, the depth of Tempus is a differentiator, but you must be prepared for the engineering investment. Overall, Tempus is a high-value platform for those who can leverage its scale and data depth, but it's not a plug-and-play solution. Evaluate your institution's data infrastructure and budget carefully.
Researching Tempus? Get your full AI stack in 60 seconds.
Free, no signup — tell us your goal and get tools matched to your budget & existing stack.
Real-world workflow fit
Concrete scenarios for the personas Tempus actually fits — and what changes day-one when you adopt it.
After a patient's biopsy, the oncologist sends a sample for Tempus xT sequencing. Within days, the clinician receives a report detailing genomic alterations, potential targeted therapies, and relevant clinical trials. Using Tempus LENS, they can also compare the patient's case to similar de-identified cases in the database.
Outcome: The oncologist makes a quicker, more informed treatment decision, potentially identifying a targeted therapy or trial that would have been missed otherwise.
A research team uses Tempus LENS to query the de-identified database to identify patient cohorts for a new drug trial. They build an AI model to predict treatment response based on genomic and clinical features.
Outcome: The team designs a more targeted trial and generates real-world evidence to support regulatory submission.
Use Cases
- Identifying targeted therapies for cancer patients based on genomic profiling
- Matching patients to clinical trials using AI and real-world data
- Accelerating drug discovery with real-world evidence for pharma
- Closing care gaps in oncology through AI-enabled analytics
- Supporting neurologists with AI-assisted notetaking (Tempus PRO)
- Identifying underdiagnosed cardiovascular patients using ECG-AI
- Evaluating therapy response in radiology with Tempus Pixel
- Providing de-identified data access for research
Models Under the Hood
as of 2026-08-31
Limitations
- Pricing is enterprise-only and not publicly disclosed, making it inaccessible for small practices.
- The platform's complexity may require dedicated IT support for integration.
- It is primarily focused on oncology, though expanding into other areas.
- Direct-to-consumer access is not available.
as of 2026-08-30
Verification history
We have re-verified Tempus 18 times since . Each pass re-reads the vendor's own pages and re-checks every listed field against that evidence; passes where nothing had changed are marked as such.
- — re-checked, vendor evidence unchanged
- — re-checked, vendor evidence unchanged
- — re-checked, vendor evidence unchanged
- — re-checked, vendor evidence unchanged
- — re-checked, vendor evidence unchanged
- — re-checked, vendor evidence unchanged
Showing the 6 most recent of 18 verification passes.
Free to cite with attribution — this page re-verifies continuously.
12-month cost
Project the real annual outlay, including the implied monthly cost when only an annual tier is published.
Vendor list price only. Add-on usage, seat overages, and contract minimums are surfaced under Hidden costs & gotchas.
Plans compared
For each published Tempus tier: who it actually fits, and what it adds vs. the previous tier. Cross-reference the cost calculator above for projected annual outlay.
Clinical
Custom
Ideal for
Large health systems and oncology practices needing comprehensive genomic profiling and AI-driven treatment insights for patient care.
What this tier adds
This is the core clinical tier, offering Tempus xT sequencing, treatment insights, clinical trial matching, and integration with your EHR. It's a starting point for clinical use.
Research
Custom
Ideal for
Pharmaceutical companies and research institutions that need access to de-identified patient data and AI model-building tools for drug discovery and real-world evidence generation.
What this tier adds
This tier adds advanced data access (7M+ records), AI model building tools, cohort analysis, and pharma collaboration features, building on the clinical data foundation.
Where the pricing makes sense
The company stage and team size where Tempus's pricing actually pencils out — and where peers do it cheaper.
Tempus pricing is tailored for large health systems and pharma enterprises with substantial budgets; it's not competitive for small practices. Compared to Foundation Medicine and Flatiron Health, Tempus offers deeper data integration but at a higher cost, and you'll need to negotiate a custom contract.
Setup time & first value
How long it actually takes to get something useful out of Tempus — broken out by persona, not the marketing-page minute.
For a large health system, initial setup including EHR integration and validating the sequencing pipeline typically takes 3-6 months. For a pharma research team, accessing data via LENS can be faster (weeks) once contracts are signed, but building custom models requires additional data science time.
Switching to or from Tempus
How to bring data in from common predecessors and how to get it back out — written for the switcher, not the buyer.
- →From Foundation Medicine: You can send additional tissue samples for Tempus xT, which provides a broader genomic panel and integrates with Tempus LENS for analytics. Expect a validation period.
- →From flatiron health: You can migrate your data workflows to Tempus LENS for more advanced AI tools and a larger de-identified dataset, but you'll need to port any custom analytics.
- ↗To Foundation Medicine: If you need a simpler, more established genomic profiling workflow, you can send samples to Foundation Medicine and rely on their reports. You'll lose Tempus's integrated analytics.
- ↗To Flatiron Health: If you want a more focused real-world evidence platform, you can transition your data access to Flatiron, but you'll need to rebuild your analytics workflows.
Integrations
Resources & Guides
Tutorials & Learning
Official links
Tools that pair well with Tempus
Common stack mates teams adopt alongside Tempus, with the specific reason each pairing earns its keep.
Flatiron Health
Oncology real-world evidence platform turning patient data into AI-powered insights for cancer research and care.
Deep 6 AI
AI-driven clinical trial patient matching and recruitment from EMR data.
Recursion Pharmaceuticals
AI-native drug discovery platform turning 50+ PB of cellular imaging data into clinical-stage therapies
Alternatives to Tempus
View allFlatiron Health
Oncology real-world evidence platform turning patient data into AI-powered insights for cancer research and care.
Recursion Pharmaceuticals
AI-native drug discovery platform turning 50+ PB of cellular imaging data into clinical-stage therapies
Frequently Asked Questions
Best-of guides
Topics
Used Tempus? Help shape our editorial sentiment research.